The manufacturers of semaglutide do not list uterine bleeding as a known or expected side effect in the product labels
SAN FRANCISCO May 20, 2025 Vida Health, a virtual, personalized obesity care provider that helps patients manage obesity and related conditions, today announced outcomes from its Clinical Obesity Management Program, which demonstrate that most patients do not require expensive GLP-1s to achieve sustainable, significant weight loss
Your work has been incredible and a cornerstone in my life
In this same study, the candidate genes BvHMA3 and BvNRAMP3 showed upregulation patterns in response to Cd-toxicity, suggesting that these candidate genes are involved in Cd uptake processes
Common Mistakes We See (And How to Avoid Catastrophe) Our team has consulted on countless research projects, and we've seen the same handful of preventable errors derail promising work